ID
13080
Beschrijving
Ophthalmologic Safety of Long Term Treatment With Pramipexole Compared to Bromocriptine or Other Dopamine Agonists in Patients With Parkinson's Disease; ODM derived from: https://clinicaltrials.gov/show/NCT02233023
Link
https://clinicaltrials.gov/show/NCT02233023
Trefwoorden
Versies (1)
- 15-01-16 15-01-16 -
Houder van rechten
CC BY-NC 3.0
Geüploaded op
15 januari 2016
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Parkinson Disease NCT02233023
Eligibility Parkinson Disease NCT02233023
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschrijving
patients who have been treated less than two and a half years (i.e. 30 months) with their actual dopamine agonist
Datatype
boolean
Alias
- UMLS CUI [1]
- C0178601
Beschrijving
ropinirole
Datatype
boolean
Alias
- UMLS CUI [1]
- C0244821
Beschrijving
hereditary retinal disease
Datatype
boolean
Alias
- UMLS CUI [1]
- C0035309
Beschrijving
drug-induced retinopathies
Datatype
boolean
Alias
- UMLS CUI [1]
- C0035309
Beschrijving
diabetic retinopathy
Datatype
boolean
Alias
- UMLS CUI [1]
- C0011884
Beschrijving
atypical parkinsonian syndromes
Datatype
boolean
Alias
- UMLS CUI [1]
- C1868596
Beschrijving
informed consent
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0021430
- UMLS CUI [1,2]
- C0439801
- UMLS CUI [1,3]
- C0009488
Beschrijving
participation in other studies
Datatype
boolean
Alias
- UMLS CUI [1]
- C2348568
Similar models
Eligibility Parkinson Disease NCT02233023
- StudyEvent: Eligibility
C0006230 (UMLS CUI [2])
C0178601 (UMLS CUI [3])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])